Bell Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Bell Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.9K	Sell	1,724 -119	-6%	-$1.66K	﹤0.01%	406
2025 Q4	$25.9K	Buy	1,843 +863	+88%	+$12.1K	﹤0.01%	374
2025 Q3	$13.7K	Buy	980 +55	+6%	+$791	﹤0.01%	530
2025 Q2	$13.9K	Buy	925 +640	+225%	+$9.14K	﹤0.01%	551
2025 Q1	$3.76K	Sell	285 -362	-56%	-$5K	﹤0.01%	1045
2024 Q4	$10.2K	Sell	647 -68	-10%	-$1.02K	﹤0.01%	598
2024 Q3	$11.4K	Hold	715	–	–	﹤0.01%	567
2024 Q2	$10.9K	Buy	715 +110	+18%	+$1.58K	﹤0.01%	575
2024 Q1	$8.88K	Buy	605 +290	+92%	+$4.23K	﹤0.01%	638
2023 Q4	$4.38K	Buy	315 +35	+13%	+$468	﹤0.01%	952
2023 Q3	$3.75K	Buy	280 +135	+93%	+$1.83K	﹤0.01%	956
2023 Q2	$1.83K	Buy	145 +95	+190%	+$1.11K	﹤0.01%	1345
2023 Q1	$570	Sell	50 -50	-50%	-$540	﹤0.01%	1765
2022 Q4	$1.03K	Buy	+100	New	+$1.08K	﹤0.01%	1572

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bell Investment Advisors's RDY Position: Q1 2026 in Review

Bell Investment Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 6.5% in Q1 2026, selling an estimated $1.66K and leaving 1,724 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #406.

Bell Investment Advisors first reported a position in RDY in Q4 2022 and has held it in 14 quarters since. The position peaked at $25.9K in Q4 2025. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Bell Investment Advisors held 1,724 shares of Dr. Reddy's Laboratories worth $23.9K as of Q1 2026.
Bell Investment Advisors sold 119 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $1.66K.
Dr. Reddy's Laboratories made up ﹤0.01% of Bell Investment Advisors's portfolio in Q1 2026, its #406 holding.
Bell Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2022 and has held it in 14 quarters since.
Bell Investment Advisors's Dr. Reddy's Laboratories position peaked at $25.9K in Q4 2025.
247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.